The Benefit/Risk Profile of TNF-Blocking Agents: Findings of a Consensus Panel
Year: 2005
Type: article
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: TNF-alpha inhibitors, infliximab, etanercept, adalimumab, rheumatoid arthritis, Crohn's disease, psoriasis, drug safety, risk-benefit profile, congestive heart failure, demyelinating disease, systemic lupus erythematosus, lymphoma, serious infections, tuberculosis screening, infusion reactions
Open Access status: closed
OpenAlex ID: W1968416967
